The Eighth Annual FLORetina – ICOOR Congress was held this year from 4th to 7th December 2025 in Florence, Italy.
Each year, ophthalmologists and retina specialists from around the globe convene to discuss and debate the most pressing issues in the field of retinal medicine.
Evired was also present this year, Pr. Aude Couturier has delivered an oral presentation on the subject of “One-Year Progression from Severe Non-Proliferative to Proliferative Diabetic Retinopathy in the EviRed Study”.
EVIRED was proud to be present at the American Academy of Ophthalmology (AAO) 2025, held this year in Orlando US.
Professor Aude Couturier presented the preliminary results of the EVIRED study on the one-year progression of diabetic retinopathy towards the proliferative stage “One-Year Progression from Severe Non-Proliferative to Proliferative Diabetic Retinopathy in the Evired Study”
Her interview by Dr Isabelle Aknin for ARMD : https://urls.fr/TvKS2b
A great opportunity to share our work and discuss the future of AI-assisted evaluation of diabetic retinopathy within large national cohorts.
From October 3–5, 2025, the LaTIM team represented by Mostafa El Habib Daho & Gwenolé Quellec participated in the Fête de la Science at the “Musée des Arts et Métiers” in Paris, to showcase our groundbreaking work within the EviRed project.
We were thrilled to present our latest advancements in AI for retinal imaging and diabetic retinopathy management to the public. The insightful and thought-provoking questions from visitors highlighted the immense curiosity and enthusiasm for science and medical innovation.
A heartfelt thank you to everyone who visited our booth and engaged in such enriching discussions!
We were delighted to attend the exciting and rewarding EURETINA 2025 meeting in Paris, held from September 4–7.
The congress was filled with informative presentations, inspiring conversations, and valuable exchanges from across the world.
The EviRed team was proudly represented with several scientific contributions:
This strong representation highlights the richness and diversity of the EviRed project.
The conference addressed the retinal diseases from multiple perspectives: medical, imaging, clinical research, treatments, surgery; and above all, questioning and discussing the rising role of artificial intelligence in this field.
Such a diverse scope enabled enriched discussions and broadened our vision of future innovations.
We return from Euretina2025 inspired, motivated, and already looking forward to next year’s meeting!
This year, the Maculart International Meeting took place in Paris from June 29th to July 1st.
The scientific program was rich and focused on retinal pathologies, including diabetic maculopathy, advances in imaging, and the integration of artificial intelligence in ophthalmology.
Dr. Patrizio Bernardinelli presented his study: “EVIRED Study: Comparative Performance of Optos and Clarus UWF Imaging for neovascularization Detection and DR Severity.” (cf. photo in the middle)
Mrs. Abir Zureik presented her study: “Evolution of Ophthalmological Care in Adults with Diabetes in France Between 2010 and 2022: A Nationwide Study.” (cf. photo on the top; on the left Mrs. Abir Zureik, on the right Pr. Aude Couturier)
The meeting brought together the world’s leading experts in macular diseases, fostering an environment of innovation and excellence.
We had the opportunity to attend insightful presentations by EVIRED SAB members Dr. Pearce Keane and Dr. Nadia Waheed. As always, Dr. Richard Spaide’s lecture on “FOVEATION” was particularly enlightening.
The principal investigators of the EVIRED study were also present. It was a valuable opportunity to learn from the contributions of Dr. Catherine Creuzot-Garcher, Dr. Laurent Kodjikian, Dr. Jean-François Korobelnik, and Dr. Alexandra Miere.
Finally, Prof. Aude Couturier provided a brief overview of the progress of the EVIRED project and the ongoing clinical study.
Looking forward to the next meeting!
We are thrilled to announce that EviRed’s new videos are now available! 🎥
The « JT de l’ophtalmologie » interview from EviRed’s team members , provides information about the mission, goals, challenges and next steps for EviRed . Listen to Pr Aude Couturier, Capucine Lepicard, Dr Sophie Bonnin, and Gwenole Quellec tell you more.
Don’t miss the interview ( in French) with Pr Pascale Massin, who provides insights into the EviRed cohort design and description. presents the first trends observed in the cohort.
Click :Here
Stay tuned for more updates !
This work benefits from State aid managed by the National Research Agency under the investment program for the Future integrated to France 2030 bearing the reference ANR-18-RHUS-0008
